AI Article Synopsis

  • Ivermectin is being tested as a topical treatment for head lice, with this study focusing on three different concentrations (0.15%, 0.25%, and 0.5%) compared to a placebo.
  • The study involved 78 participants of varying ages applying the lotion once for 10 minutes, with evaluations for effectiveness and safety conducted over 15 days.
  • Results showed all ivermectin concentrations effectively eradicated lice, with the 0.5% concentration being the most effective and well-tolerated, also reducing itchiness significantly.

Article Abstract

Background: Ivermectin is a broad-spectrum parasiticide in widespread systemic use, including as an off-label treatment for head lice infestation. The potential of the topical use of ivermectin as a treatment for head lice infestation was suggested by an in vitro report of a novel lotion formulation.

Objectives: This study investigated the relative effectiveness of three ivermectin lotion concentrations (0.15, 0.25, and 0.5%) compared with vehicle placebo in eliminating head lice infestation.

Methods: In this randomized, blinded study, 78 head lice-infested subjects, aged 2-62 years, received a single, 10-minute application of product on day 1. Evaluations were completed at two and six hours post-application, and on days 2, 8 (±1), and 15 (+2). Safety was assessed according to the evaluations of trained observers and adverse event (AE) reports. Efficacy was assessed according to scalp and hair examinations.

Results: Compared with placebo, all ivermectin concentrations resulted in the statistically significant (P ≤ 0.003) eradication of head lice through to day 15, with the highest level of eradication (73.7%) in subjects who received the 0.5% concentration. The severity of pruritus decreased from baseline in all treatment groups, including the placebo group, from six hours post-treatment to day 15, with the greatest reduction in the 0.5% concentration group. No ocular irritation was observed. All three ivermectin treatment strengths and vehicle were well tolerated.

Conclusions: A single application of a 0.5% concentration of this ivermectin lotion formulation shows promise as a safe and effective treatment for head lice infestation and the associated signs of pruritus.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-4632.2012.05629.xDOI Listing

Publication Analysis

Top Keywords

head lice
24
treatment head
16
lice infestation
16
ivermectin lotion
12
05% concentration
12
topical ivermectin
8
ivermectin treatment
8
three ivermectin
8
ivermectin
7
head
7

Similar Publications

Bartonella quintana Endocarditis Associated With Head Lice in a Canadian Indigenous Youth.

Pediatr Infect Dis J

December 2024

From the Division of Infectious Diseases, Department of Paediatrics.

Bartonella quintana is a rare but important cause of culture-negative endocarditis, classically associated with body lice infestation. We report the first known pediatric case of Bartonella quintana endocarditis associated with head lice. The importance of sending targeted testing for this organism in at-risk patients, ideally on tissue specimens, is emphasized.

View Article and Find Full Text PDF
Article Synopsis
  • - Bartonella quintana can lead to serious health issues, including endocarditis and chronic infections, and is mainly spread by body lice, particularly in homeless populations.
  • - A case study in the U.S. highlighted two kidney transplant recipients who contracted the infection from an organ donor who was homeless; one case was atypical while the other showed mild symptoms.
  • - Timely detection and treatment allowed both recipients to recover, emphasizing the importance of assessing organ donors' living conditions, specifically those with a history of homelessness or lice infestations, for potential B. quintana infections in transplant recipients.
View Article and Find Full Text PDF
Article Synopsis
  • Bartonella quintana infection can cause serious health issues like bacillary angiomatosis and culture-negative endocarditis, mainly affecting individuals who are homeless.
  • In a study conducted in New York City between January 2020 and November 2023, five cases of left-sided, culture-negative endocarditis were identified in unsheltered homeless persons using molecular methods.
  • Most patients had serious complications and a history of body louse exposure, highlighting the need for clinicians to consider housing status and potential lice infestation when diagnosing and treating suspected cases.
View Article and Find Full Text PDF
Article Synopsis
  • Louseborne Bartonella quintana infections mainly affect homeless individuals in the U.S. due to poor hygiene resources, and these infections can impact organ transplant recipients.
  • The increase in homelessness raises concerns about the transmission of B. quintana through organ donations from former homeless donors.
  • To reduce B. quintana transmission, interventions like better housing access, hygiene resources, early treatment of infections, and testing/prophylactic treatments for transplant recipients are necessary.
View Article and Find Full Text PDF

Prevalence of pediculosis among primary school children in Tunisia.

East Mediterr Health J

September 2024

Medical and Molecular Parasitology-Mycology Laboratory, Department of Clinical Biology B, Faculty of Pharmacy, University of Monastir, Tunisia.

Article Synopsis
  • Study aims to investigate head lice prevalence among primary school children in Monastir, Tunisia, due to its global health impact and lack of local research.
  • A total of 2396 children from 14 schools were examined, revealing a 17.5% infestation rate, significantly higher in girls (29.1%) compared to boys (6.3%).
  • Factors such as crowded living conditions, grade level, and parents' education were linked to higher infestation risk, underlining the need for preventive measures and health programs targeting children and their communities.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!